Mounjaro launch India – The Milli Chronicle

Monday, October 6, 2025

Latest:

Indian Power Regulator Moves to Support Solar Developers Amid Transmission Expansion
Rupee Steady as RBI Support and Strong Market Activity Bolster Confidence
Eli Lilly Commits Over $1 Billion to Expand Manufacturing and Healthcare Innovation in India
Germany Boosts Green Industry with €6 Billion Decarbonisation Initiative Featuring CCS Technology
Barrick Strengthens Global Portfolio with Strategic $305 Million Tongon Mine Deal

Factual Version of a Story

Asia Latest News

NewsDesk Milli Chronicle October 6, 2025October 6, 2025 Alzheimer’s drug India, autoimmune medication India, biotech jobs India, cancer treatment India, contract manufacturing India, diabetes medication India, Eli Lilly investment India, global drug supply, healthcare innovation India, Hyderabad manufacturing facility, Mounjaro launch India, obesity treatment India, pharma industry growth India, pharmaceutical manufacturing India, skilled workforce India.

Eli Lilly Commits Over $1 Billion to Expand Manufacturing and Healthcare Innovation in India

Bengaluru – Eli Lilly announces major investment in India to boost drug manufacturing, create jobs, and enhance patient access to